140 results on '"Brusko, Todd M."'
Search Results
2. Data-driven selection of analysis decisions in single-cell RNA-seq trajectory inference
3. The immunology of type 1 diabetes
4. The Post-Septic Peripheral Myeloid Compartment Reveals Unexpected Diversity in Myeloid-Derived Suppressor Cells
5. Data-driven selection of analysis decisions in single-cell RNA-seq trajectory inference
6. NADPH Oxidase 2–Derived Reactive Oxygen Species Promote CD8+ T Cell Effector Function
7. Characterizing cell-type spatial relationships across length scales in spatially resolved omics data
8. Human immune phenotyping reveals accelerated aging in type 1 diabetes
9. Treg-specific CD226 Deletion Reduces Diabetes Incidence in NOD Mice by Improving Regulatory T Cell Stability
10. Responders to low-dose ATG induce CD4+ T cell exhaustion in type 1 diabetes
11. Insulin-like Growth Factor-1 Synergizes with IL-2 to Induce Homeostatic Proliferation of Regulatory T Cells
12. Site-specific development and progressive maturation of human tissue-resident memory T cells over infancy and childhood
13. DHCR7 Expression Predicts Poor Outcomes and Mortality From Sepsis
14. Modeling cell-mediated immunity in human type 1 diabetes by engineering autoreactive CD8+ T cells
15. A genomic data archive from the Network for Pancreatic Organ donors with Diabetes
16. Data from Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment
17. Data from Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment
18. Supplementary Figures 1 through 3 from Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment
19. Supplementary Figures 1 through 3 from Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment
20. Human immune phenotyping reveals accelerated aging in type 1 diabetes
21. DHCR7 Expression Predicts Poor Outcomes and Mortality from Sepsis
22. Immune engineered extracellular vesicles to modulate T cell activation in the context of type 1 diabetes
23. Biomaterials‐based nanoparticles conjugated to regulatory T cells provide a modular system for localized delivery of pharmacotherapeutic agents
24. Deletion of CD226 in Foxp3+ T cells Reduces Diabetes Incidence in Non-Obese Diabetic Mice by Improving Regulatory T Cell Stability and Function
25. 189-OR: Immune-Profiling of Pancreatic Tissue Affected by Immune Checkpoint Inhibitor–Induced Diabetes (CPI-D)
26. Human CD4+CD25+CD226- Tregs Demonstrate Increased Purity, Lineage Stability, and Suppressive Capacity Versus CD4+CD25+CD127lo/- Tregs for Adoptive Cell Therapy
27. Insulin-like Growth Factor-1 Synergizes with IL-2 to Induce Homeostatic Proliferation of Regulatory T cells
28. Improving the Prediction of Type 1 Diabetes Across Ancestries
29. Infant T cells are developmentally adapted for robust lung immune responses through enhanced T cell receptor signaling
30. SARS-CoV-2 infection generates tissue-localized immunological memory in humans
31. Autoreactive T cell receptors with shared germline-like α chains in type 1 diabetes
32. The immuneML ecosystem for machine learning analysis of adaptive immune receptor repertoires
33. Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 Diabetes
34. Immune, endothelial and neuronal network map in human lymph node and spleen
35. Editorial: Footprints of Immune Cells in the Type 1 Diabetic Pancreas
36. A hypolipoprotein sepsis phenotype indicates reduced lipoprotein antioxidant capacity, increased endothelial dysfunction and organ failure, and worse clinical outcomes
37. The Immunoregulatory Role of the Signal Regulatory Protein Family and CD47 Signaling Pathway in Type 1 Diabetes
38. CAR- and TRuC-redirected regulatory T cells differ in capacity to control adaptive immunity to FVIII
39. A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis
40. Overexpression of the PTPN22 Autoimmune Risk Variant LYP-620W Fails to Restrain Human CD4+ T Cell Activation
41. Strategies for durable β cell replacement in type 1 diabetes
42. Lupus susceptibility gene Esrrg modulates regulatory T cells through mitochondrial metabolism
43. 192-LB: Human CD4+CD25+CD226- Regulatory T Cells Demonstrate High Purity and Lineage Stability following In Vitro Expansion for Adoptive Cell Therapy
44. Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 Diabetes
45. immuneML: an ecosystem for machine learning analysis of adaptive immune receptor repertoires
46. Low-dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report
47. Low-dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report
48. Low-Dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report
49. NADPH Oxidase 2 Derived Reactive Oxygen Species Promote CD8+ T cell Effector Function
50. De‐ coding genetic risk variants in type 1 diabetes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.